31 related articles for article (PubMed ID: 22493387)
1. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.
Wei Y; Wang L; Jin Z; Jia Q; Brcic L; Akaba T; Chu Q
Transl Lung Cancer Res; 2024 Mar; 13(3):635-653. PubMed ID: 38601447
[TBL] [Abstract][Full Text] [Related]
2. [Current Status of Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma].
Liu L; Zang R; Song P; Gao S
Zhongguo Fei Ai Za Zhi; 2018 Dec; 21(12):902-906. PubMed ID: 30591097
[TBL] [Abstract][Full Text] [Related]
3. Serological Assessment of Activated Fibroblasts by alpha-Smooth Muscle Actin (α-SMA): A Noninvasive Biomarker of Activated Fibroblasts in Lung Disorders.
Holm Nielsen S; Willumsen N; Leeming DJ; Daniels SJ; Brix S; Karsdal MA; Genovese F; Nielsen MJ
Transl Oncol; 2019 Feb; 12(2):368-374. PubMed ID: 30504086
[TBL] [Abstract][Full Text] [Related]
4. Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities.
Willumsen N; Thomsen LB; Bager CL; Jensen C; Karsdal MA
Cancer Immunol Immunother; 2018 Jan; 67(1):1-12. PubMed ID: 29022089
[TBL] [Abstract][Full Text] [Related]
5. Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.
Moro M; Bertolini G; Caserini R; Borzi C; Boeri M; Fabbri A; Leone G; Gasparini P; Galeone C; Pelosi G; Roz L; Sozzi G; Pastorino U
Sci Rep; 2017 Jul; 7(1):6689. PubMed ID: 28751748
[TBL] [Abstract][Full Text] [Related]
6. Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma.
Takeda K; Matsushita H; Kubozono M; Tanabe T; Ishikawa Y; Yamamoto T; Kozumi M; Takahashi N; Katagiri Y; Tasaka S; Fukui K; Takeda K; Fujishima F; Ichinose M; Jingu K
Intern Med; 2016; 55(22):3325-3330. PubMed ID: 27853077
[TBL] [Abstract][Full Text] [Related]
7. Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.
Pelosi G; Perrone F; Tamborini E; Fabbri A; Testi MA; Busico A; Settanni G; Picciani B; Bovio E; Sonzogni A; Valeri B; Garassino M; De Braud F; Pastorino U
Virchows Arch; 2016 Apr; 468(4):451-61. PubMed ID: 26818831
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Willumsen N; Bager CL; Leeming DJ; Smith V; Christiansen C; Karsdal MA; Dornan D; Bay-Jensen AC
Cancer Med; 2014 Oct; 3(5):1136-45. PubMed ID: 25044252
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary pleomorphic carcinoma with multiple metastases to the right posterior knee complicated by paraneoplastic hypercalcemia.
Li PF; Lo CH; Yang SH; Chung PY; Ho CL
Oncol Lett; 2014 Feb; 7(2):452-454. PubMed ID: 24396467
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.
Huang SY; Shen SJ; Li XY
World J Surg Oncol; 2013 Oct; 11():252. PubMed ID: 24088577
[TBL] [Abstract][Full Text] [Related]
11. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
Spieler P; Gloor F
Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
[TBL] [Abstract][Full Text] [Related]
12. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
[TBL] [Abstract][Full Text] [Related]
14. Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma.
Baldovini C; Rossi G; Ciarrocchi A
Lung Cancer (Auckl); 2019; 10():131-149. PubMed ID: 31824199
[TBL] [Abstract][Full Text] [Related]
15. A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples.
Pelosi G; Melotti F; Cavazza A; Rossi G; Maisonneuve P; Graziano P; Barbareschi M; Nakatani Y; Papotti M
Anticancer Res; 2012 Apr; 32(4):1463-73. PubMed ID: 22493387
[TBL] [Abstract][Full Text] [Related]
16. Review article: pulmonary sarcomatoid carcinomas: a practical overview.
Pelosi G; Sonzogni A; De Pas T; Galetta D; Veronesi G; Spaggiari L; Manzotti M; Fumagalli C; Bresaola E; Nappi O; Viale G; Rosai J
Int J Surg Pathol; 2010 Apr; 18(2):103-20. PubMed ID: 19124452
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
